Access to Affordable Life-Saving Medications

What it means

This order requires Federally Qualified Health Centers to make insulin and injectable epinephrine available at discounted prices to low-income individuals. Centers must establish practices to offer these medications at the same low price they pay through the 340B Drug Program.

Expected impact

• Increased access to affordable insulin and injectable epinephrine for uninsured and underinsured Americans
• Potential financial relief for low-income patients with diabetes or severe allergies who previously struggled with high medication costs
• Federally Qualified Health Centers will need to implement new systems to identify eligible patients and provide discounted medications
• May help address the issue of rising insulin prices, which have increased dramatically over the past decade